{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T11:04:47Z","timestamp":1760267087287},"reference-count":25,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Revue des Maladies Respiratoires"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1016\/j.rmr.2010.08.018","type":"journal-article","created":{"date-parts":[[2011,3,16]],"date-time":"2011-03-16T08:29:35Z","timestamp":1300264175000},"page":"360-364","source":"Crossref","is-referenced-by-count":12,"title":["Sarco\u00efdose pulmonaire apparue sous \u00e9tanercept"],"prefix":"10.1016","volume":"28","author":[{"given":"M.","family":"Kerjouan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Jouneau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Lena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Luraine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Desrues","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Delaval","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmr.2010.08.018_bib0005","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/QCO.0b013e32832dda55","article-title":"Infectious complications of tumor necrosis factor blockade","volume":"22","author":"Wallis","year":"2009","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.rmr.2010.08.018_bib0010","doi-asserted-by":"crossref","unstructured":"Solovic I, Sester M, Gomez-Reino JJ, et al. The risk of tuberculosis related to TNF antagonist therapies: a TBNET consensus statement. Eur Respir J 2010;36:1185\u2013206.","DOI":"10.1183\/09031936.00028510"},{"key":"10.1016\/j.rmr.2010.08.018_bib0015","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1398-9995.2005.00778.x","article-title":"Pulmonary sarcoidosis","volume":"60","author":"Nunes","year":"2005","journal-title":"Allergy"},{"key":"10.1016\/j.rmr.2010.08.018_bib0020","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1378\/chest.127.3.1064","article-title":"Treatment of sarcoidosis with infliximab","volume":"127","author":"Doty","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.rmr.2010.08.018_bib0025","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1183\/09031936.00051907","article-title":"Efficacy of infliximab in extrapulmonary sarcoidosis: results from a randomised trial","volume":"31","author":"Judson","year":"2008","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmr.2010.08.018_bib0030","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1164\/rccm.200603-402OC","article-title":"Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement","volume":"174","author":"Baughman","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmr.2010.08.018_bib0035","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1378\/chest.124.1.177","article-title":"Etanercept for the treatment of stage II and III progressive pulmonary sarcoidosis","volume":"124","author":"Utz","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.rmr.2010.08.018_bib0040","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1378\/chest.122.5.1858","article-title":"Lung injury linked to etanercept therapy","volume":"122","author":"Peno-Green","year":"2002","journal-title":"Chest"},{"key":"10.1016\/j.rmr.2010.08.018_bib0045","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1136\/thorax.58.3.278","article-title":"Pulmonary granulomas after tumour necrosis factor alpha antagonist therapy","volume":"58","author":"Vavricka","year":"2003","journal-title":"Thorax"},{"key":"10.1016\/j.rmr.2010.08.018_bib0050","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1002\/art.11154","article-title":"Pulmonary rheumatoid nodules in an etanercept-treated patient","volume":"48","author":"Hubscher","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rmr.2010.08.018_bib0055","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/art.21336","article-title":"Granulomatous lung disease occurring during etanercept treatment","volume":"53","author":"Phillips","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rmr.2010.08.018_bib0060","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1002\/art.22351","article-title":"Pulmonary sarcoidosis developing during infliximab therapy","volume":"55","author":"O'Shea","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rmr.2010.08.018_bib0065","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1007\/s10067-007-0594-1","article-title":"Development of sarcoidosis in etanercept-treated rheumatoid arthritis patients","volume":"26","author":"Verschueren","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.rmr.2010.08.018_bib0070","first-page":"648","article-title":"Sarcoid-like granulomatous disease following etanercept treatment for RA","volume":"34","author":"Kudrin","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1016\/j.rmr.2010.08.018_bib0075","first-page":"99","article-title":"Pulmonary sarcoidosis in a patient with ankylosing spondylitis treated with infliximab","volume":"25","author":"Almodovar","year":"2007","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.rmr.2010.08.018_bib0080","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.2169\/internalmedicine.47.0602","article-title":"Development of sarcoidosis during etanercept therapy","volume":"47","author":"Ishiguro","year":"2008","journal-title":"Intern Med"},{"key":"10.1016\/j.rmr.2010.08.018_bib0085","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.semarthrit.2008.11.003","article-title":"Sarcoidosis appearing during anti-tumor necrosis factor alpha therapy: a new \u201cclass effect\u201d paradoxical phenomenon. Two case reports and literature review","volume":"39","author":"Massara","year":"2010","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.rmr.2010.08.018_bib0090","first-page":"471","article-title":"Sarcoidosis occuring during anti-TNF-alpha treatment for inflammatory rheumatic diseases: report of two cases","volume":"26","author":"Toussirot","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.rmr.2010.08.018_bib0095","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.jbspin.2009.02.003","article-title":"Infliximab induced skin and pulmonary sarcoidosis in a rheumatoid arthritis patient","volume":"76","author":"Josse","year":"2009","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.rmr.2010.08.018_bib0100","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1093\/rheumatology\/kep046","article-title":"Sarcoid-like granulomatosis in patients treated with tumor necrosis factor blockers: 10\u00a0cases","volume":"48","author":"Daien","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.rmr.2010.08.018_bib0105","doi-asserted-by":"crossref","unstructured":"Toussirot E, Pertuiset E. TNFalpha blocking agents and sarcoidosis: an update. Rev Med Interne 2010;31:828\u201337.","DOI":"10.1016\/j.revmed.2010.02.007"},{"key":"10.1016\/j.rmr.2010.08.018_bib0110","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s00296-007-0483-6","article-title":"A co-occurrence of sarcoidosis and ankylosing spondylitis: a case report","volume":"28","author":"Sezer","year":"2008","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.rmr.2010.08.018_bib0115","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1128\/JCM.40.1.198-204.2002","article-title":"Quantitative analysis of mycobacterial and propionibacterial DNA in lymph nodes of Japanese and European patients with sarcoidosis","volume":"40","author":"Eishi","year":"2002","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.rmr.2010.08.018_bib0120","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1440-1843.2005.00746.x","article-title":"Sarcoidosis caused by interferon therapy","volume":"10","author":"Celik","year":"2005","journal-title":"Respirology"},{"key":"10.1016\/j.rmr.2010.08.018_bib0125","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.semarthrit.2006.02.001","article-title":"Tumor necrosis factor antagonists: different kinetics and\/or mechanisms of action may explain differences in the risk for developing granulomatous infection","volume":"36","author":"Furst","year":"2006","journal-title":"Semin Arthritis Rheum"}],"container-title":["Revue des Maladies Respiratoires"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0761842511000611?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0761842511000611?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,9]],"date-time":"2019-06-09T08:22:20Z","timestamp":1560068540000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0761842511000611"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S0761842511000611"],"URL":"https:\/\/doi.org\/10.1016\/j.rmr.2010.08.018","relation":{},"ISSN":["0761-8425"],"issn-type":[{"value":"0761-8425","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]}}}